Utilico Emerging Markets Limited
16 October 2007
UTILICO EMERGING MARKETS LIMITED ('the Company')
16 October 2007
Directors' Dealings
The Company announces that the following ordinary shares of 10p each in the
Company have today been allotted to Directors in satisfaction of their
remuneration for the quarter end ended 30 September 2007, in accordance with
their fee entitlements as detailed in the Company's Admission Document dated 14
July 2005:
Director Fee shares allotted Resultant shareholding %
A Zagoreos 4,617 290,459 0.17
C D O Jillings 3,170 677,955 0.41
G A Madeiros 3,962 4,560 0.00
G P D Milne 3,170 459,080 0.28
K J O'Connor 3,170 408,602 0.25
Application has therefore been made for the admission to trading on AIM of
18,089 ordinary shares of 10p each in the Company ('Admission'). Upon Admission
these Shares will rank pari passu with the Company's existing issued ordinary
shares and dealings are expected to commence on 23 October 2007. Application
has also been made for listing on the Bermuda Stock Exchange.
Following Admission the Company will have 166,344,339 Shares and 32,542,518
Warrants to subscribe for Shares in issue.
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.